CJC-1295 from NXTSTATE is a research-grade peptide tested at ≥99% HPLC purity. A third-party Certificate of Analysis is included on every lot. Below you will find specifications, research applications, and the standards every shipment meets.

Product Overview

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 30 amino acids. It was originally developed to increase plasma growth hormone and insulin-like growth factor 1 (IGF-1) levels in research models. CJC-1295 is one of the most widely studied GHRH analogs in peptide research due to its modified structure that provides enhanced stability and extended half-life compared to native GHRH.

NXTSTATE supplies CJC-1295 in lyophilized form at research-grade purity, verified by independent third-party HPLC and mass spectrometry analysis. Each vial ships with a Certificate of Analysis documenting purity, identity, and batch-specific quality metrics.

Research Background

CJC-1295 has been the subject of extensive preclinical and clinical investigation for its effects on growth hormone secretion. The peptide works by binding to GHRH receptors on pituitary somatotroph cells, stimulating the synthesis and release of growth hormone in a pulsatile manner that mimics natural physiological patterns.

Research has examined CJC-1295 in multiple contexts including body composition studies, metabolic rate investigations, bone density research, and sleep architecture analysis. Studies have demonstrated sustained elevation of GH and IGF-1 levels following administration, with effects lasting significantly longer than native GHRH due to resistance to enzymatic degradation by dipeptidyl peptidase IV (DPP-IV).

CJC-1295 is frequently studied alongside growth hormone secretagogues such as Ipamorelin and GHRP-6, as combination protocols are hypothesized to produce synergistic effects on GH release through complementary receptor pathways. Researchers studying neuroendocrine signaling, metabolic regulation, and peptide pharmacokinetics have found CJC-1295 to be a valuable investigational tool.

Product Specifications

• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Appearance: White to off-white powder
• Storage: Store at -20°C for long-term, 2-8°C after reconstitution

Quality Assurance

Every batch of CJC-1295 from NXTSTATE undergoes comprehensive quality control testing including HPLC purity analysis, mass spectrometry identification, and endotoxin screening. Our manufacturing partners maintain strict quality protocols to ensure batch-to-batch consistency and reliability for research applications.

Reconstitution and Handling

Reconstitute CJC-1295 with bacteriostatic water using aseptic technique. Add solvent slowly along the vial wall and gently swirl to dissolve. Do not shake vigorously. Once reconstituted, store at 2-8°C and use within 30 days. The lyophilized powder should remain at -20°C until preparation. Avoid repeated freeze-thaw cycles and exposure to direct light.

Compliance and Disclaimers

• For Research Use Only (RUO)
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease
• Not approved for medical, cosmetic, food, or veterinary use
• The buyer assumes all responsibility for proper handling, storage, and use
• Must comply with all applicable local, state, and federal regulations

By purchasing this product, the buyer acknowledges it is being sold solely for research purposes and accepts all associated responsibility.

Related Research on CJC-1295

Researchers often pair CJC-1295 with complementary compounds in the NXTSTATE catalog. Explore the full lab report library for third-party COAs on every lot, or browse the complete catalog for related research peptides. Independent peer-reviewed background is available through the PubMed research database.

Quality Standards Behind Every CJC-1295 Lot

Every lot leaving the NXTSTATE facility passes independent third-party HPLC testing. The Certificate of Analysis is matched to the batch number printed on each vial. Researchers can verify the COA before opening the package, then again at the bench. This level of transparency separates research-grade supply from grey-market sources.

Storage matters as much as sourcing. Each vial ships in lyophilized form with a desiccant pack and should be stored at -20°C until reconstituted. After reconstitution, refrigerate at 2-8°C. Following these conditions preserves potency throughout the research timeline. Cold-chain handling guidance ships with every order.